Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1516
-
Total 13F shares, excl. options
-
992,982,498
-
Shares change
-
-32,850,918
-
Total reported value, excl. options
-
$70,297,342,536
-
Value change
-
-$2,364,209,399
-
Put/Call ratio
-
1.69%
-
Number of buys
-
599
-
Number of sells
-
-824
-
Price
-
$70.84
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2018
1,697 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2018.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,516 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 992,982,498 shares
of 1,240,722,841 outstanding shares and own 80.03% of the company stock.
Largest 10 shareholders include BlackRock Inc. (105,230,660 shares), VANGUARD GROUP INC (96,095,710 shares), Capital Research Global Investors (57,036,667 shares), STATE STREET CORP (54,437,317 shares), FMR LLC (19,587,054 shares), PARNASSUS INVESTMENTS /CA (19,526,902 shares), Invesco Ltd. (17,840,325 shares), NORTHERN TRUST CORP (16,823,192 shares), PRICE T ROWE ASSOCIATES INC /MD/ (16,266,811 shares), and DODGE & COX (16,259,811 shares).
This table shows the top 1516 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.